Bench-to-bedside development of multifunctional flexible embolic agents

Theranostics. 2023 Apr 1;13(7):2114-2139. doi: 10.7150/thno.80213. eCollection 2023.

Abstract

Transarterial chemoembolization (TACE) has been demonstrated to provide a survival benefit for patients with unresectable hepatocellular carcinoma (HCC). However, conventional TACE still faces limitations associated with complications, side effects, unsatisfactory tumor responses, repeated treatment, and narrow indications. For further improvement of TACE, additional beneficial functions such as degradability, drug-loading and releasing properties, detectability, targetability, and multiple therapeutic modalities were introduced. The purpose here is to provide a comprehensive overview of current and emerging particulate embolization technology with respect to materials. Therefore, this review systematically identified and described typical features, various functions, and practical applications of recently emerging micro/nano materials as particulate embolic agents for TACE. Besides, new insights into the liquid metals-based multifunctional and flexible embolic agents were highlighted. The current development routes and future outlooks of these micro/nano embolic materials were also presented to promote advancement in the field.

Keywords: Ga based liquid metal; Hepatocellular carcinoma (HCC); Micro/nano materials; Multifunctional flexible embolic agents; Particulate embolic agents; Transarterial chemoembolization (TACE).

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular* / pathology
  • Chemoembolization, Therapeutic* / methods
  • Humans
  • Liver Neoplasms* / pathology
  • Treatment Outcome